Compared to both 1D8 IgG and 1D8N18, 1D8N/CEGa1 was a more potent costimulator in vitro and showed enhanced tumor homing and tumor inhibition in vivo, with no indication of the 4-1BB mAb-associated toxicity. This evidence concerns the gene TNFRSF9 and neoplasm.